A new study identifies the NFATC2::NUTM2 fusion as a defining feature of a novel primary pulmonary epithelial tumor, highlighting its unique immunophenotype. This discovery could pave the way for targeted therapies and improved diagnostics.
nfatc2 nutm2 fusion defines a novel primary pulmonary epithelial tumor with a distinctive immunophenotype
Original title: “NFATC2::NUTM2 Fusion Defines a Novel Primary Pulmonary Epithelial Tumor With a Distinctive Immunophenotype.”